SEPTInvestingStart Free

PACB SCHEDULE 13G: SEC filing

Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC

Filed with the SEC on · accession 0000886982-26-000587

PACB filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 9, 2026. Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of 23,515,935 shares, or 7.6%, of Pacific Biosciences of California, Inc. common stock as of September 30, 2026. The stock moved +4.7% by the first close after the filing.

Summary of the filing

Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of 23,515,935 shares, or 7.6%, of Pacific Biosciences of California, Inc. common stock as of September 30, 2026. The filing is a passive institutional ownership disclosure under Rule 13d-1(b).

For details, click here →

Key details

Shares beneficially owned$23.5M
Percent of class beneficially ownedPCT 8
Reporting beneficial owner / parent holding companyThe Goldman Sachs Group, Inc.
Reporting beneficial owner / broker-dealer and investment adviser subsidiaryGoldman Sachs & Co. LLC
Issuer of the securitiesPacific Biosciences of California, Inc.
Attorney-in-factAmeen Soetan

How PACB stock reacted

Close before

$2.25

Nov 6, 2026

First close after

+4.66%

$2.36

5 trading days

—

Since filing

-0.67%

$2.24

✦ Ask GOAX AI about this filing — what it means for PACB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PACB?

Click here

Frequently asked questions

What did PACB file with the SEC on Nov 9, 2026?

PACB filed a SCHEDULE 13G (SEC filing). Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of 23,515,935 shares, or 7.6%, of Pacific Biosciences of California, Inc. common stock as of September 30, 2026. The filing is a passive institutional ownership disclosure under Rule 13d-1(b).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did PACB stock react to this filing?

PACB closed at $2.25 before the filing and $2.36 on Nov 9, 2026 (+4.66%).

Other PACB SEC filings

Get alerts when PACB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
PACB overviewPACB analysisPACB newsLatest SEC filings